Profound Medical (PROF) Net Income towards Common Stockholders Growth (1y) (2025 - 2026)

Profound Medical (PROF) Net Income towards Common Stockholders Growth (1y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income Growth (1y) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-47.84%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	44.34%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	18.55%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	13.80%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-27.18%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	38.54%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	14.80%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	73.85%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	12.92%
10	Profound Medical	247.18 Mn	208.91 Mn	1.95 Mn	39.22%

Download Data